摘要
目的:探讨眼肌麻痹的临床病因及复方樟柳碱注射液治疗眼肌麻痹的临床疗效。方法:收治眼肌麻痹患者66例,给予复方樟柳碱注射液治疗,分析临床病因及临床疗效。结果:神经血管源性麻痹53例(80.3%),全身免疫性麻痹5例(7.6%),肌源性麻痹5例(7.6%),机械性损伤4例(6.1%)。治愈率63.6%,总有效率90.9%。结论:复方樟柳碱注射液治疗眼肌麻痹的临床疗效较好。
Objective:To investigate the etiology of ophthalmoplegia and the clinical curative effect of compound anisodinehydrobromide injection in the treatment of ophthalmoplegia.Methods:66cases of patients with ophthalmoplegia were treated withcompound anisodine hydrobromide injection,and the etiology and clinical curative effect was analyzed.Results:53cases wereneurogenic vascular paralysis(80.3%),and5cases were systemic immune paralysis(7.6%).5cases were muscular paralysis(7.6%),and4cases were mechanical injury(6.1%).The cure rate was63.6%,and the total effective rate was90.9%.Conclusion:Compoundanisodine hydrobromide injection in the treatment of ophthalmoplegia had better clinical curative effect.
作者
段燕萍
Duan Yanping(Kunming Iron and Steel Group Hospital in Yunnan,650300)
出处
《中国社区医师》
2017年第6期21-22,共2页
Chinese Community Doctors
关键词
复方樟柳碱注射液
眼肌麻痹
临床病因
Compound anisodine hydrobromide injection
Ophthalmoplegia
Etiology
